 Population pharmacokinetics intravenous indomethacin neonates symptomatic patent ductus arteriosus population pharmacokinetics intravenous indomethacin indomethacin serum concentrations neonates mean SD gestational age weeks postnatal age days birth weight kg indomethacin symptomatic patent ductus arteriosus one-compartment open model pharmacokinetic analysis Hypotheses developmental demographic data clearance CL volume distribution area final regression equation CL area function body weight postnatal age PNA days Final estimates CL ml/hr kg days area kg days coefficients variation interindividual variability CL area Intraindividual variability mean population parameter estimates useful dosage regimens indomethacin concentrations neonates days age symptomatic patent ductus arteriosus